Yu AM - Search Results

1

RNA therapy: Are we using the right molecules?

Yu AM, Jian C, Yu AH, Tu MJ. Yu AM, et al. Among authors: yu ah. Pharmacol Ther. 2019 Apr;196:91-104. doi: 10.1016/j.pharmthera.2018.11.011. Epub 2018 Dec 4. Pharmacol Ther. 2019. PMID: 30521885 Free PMC article. Review.

2

Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.

Li MM, Addepalli B, Tu MJ, Chen QX, Wang WP, Limbach PA, LaSalle JM, Zeng S, Huang M, Yu AM. Li MM, et al. Among authors: yu am. Drug Metab Dispos. 2015 Jul;43(7):1129-36. doi: 10.1124/dmd.115.064493. Epub 2015 May 1. Drug Metab Dispos. 2015. PMID: 25934574 Free PMC article.

3

Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization.

Wang WP, Ho PY, Chen QX, Addepalli B, Limbach PA, Li MM, Wu WJ, Jilek JL, Qiu JX, Zhang HJ, Li T, Wun T, White RD, Lam KS, Yu AM. Wang WP, et al. Among authors: yu am. J Pharmacol Exp Ther. 2015 Aug;354(2):131-41. doi: 10.1124/jpet.115.225631. Epub 2015 May 28. J Pharmacol Exp Ther. 2015. PMID: 26022002 Free PMC article.

4

Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.

Zhao Y, Tu MJ, Yu YF, Wang WP, Chen QX, Qiu JX, Yu AX, Yu AM. Zhao Y, et al. Among authors: yu ax, yu am, yu yf. Biochem Pharmacol. 2015 Dec 15;98(4):602-13. doi: 10.1016/j.bcp.2015.10.015. Epub 2015 Oct 27. Biochem Pharmacol. 2015. PMID: 26518752 Free PMC article.

5

MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Yu AM, Tian Y, Tu MJ, Ho PY, Jilek JL. Yu AM, et al. Drug Metab Dispos. 2016 Mar;44(3):308-19. doi: 10.1124/dmd.115.067470. Epub 2015 Nov 13. Drug Metab Dispos. 2016. PMID: 26566807 Free PMC article. Review.

6

Bioengineering of noncoding RNAs for research agents and therapeutics.

Ho PY, Yu AM. Ho PY, et al. Among authors: yu am. Wiley Interdiscip Rev RNA. 2016 Mar-Apr;7(2):186-97. doi: 10.1002/wrna.1324. Epub 2016 Jan 13. Wiley Interdiscip Rev RNA. 2016. PMID: 26763749 Free PMC article. Review.

7

Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest.

Zhao Y, Tu MJ, Wang WP, Qiu JX, Yu AX, Yu AM. Zhao Y, et al. Among authors: yu ax, yu am. Sci Rep. 2016 May 24;6:26611. doi: 10.1038/srep26611. Sci Rep. 2016. PMID: 27216562 Free PMC article.

8

MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis.

Tu MJ, Pan YZ, Qiu JX, Kim EJ, Yu AM. Tu MJ, et al. Among authors: yu am. Oncotarget. 2016 Jul 19;7(29):45547-45561. doi: 10.18632/oncotarget.9999. Oncotarget. 2016. PMID: 27322206 Free PMC article.

9

Bioengineered non-coding RNA agent (BERA) in action.

Duan Z, Yu AM. Duan Z, et al. Among authors: yu am. Bioengineered. 2016 Nov;7(6):411-417. doi: 10.1080/21655979.2016.1207011. Epub 2016 Jul 14. Bioengineered. 2016. PMID: 27415469 Free PMC article. Review.

10

Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling.

Francois LN, Gorczyca L, Du J, Bircsak KM, Yen E, Wen X, Tu MJ, Yu AM, Illsley NP, Zamudio S, Aleksunes LM. Francois LN, et al. Among authors: yu am. Placenta. 2017 Mar;51:57-63. doi: 10.1016/j.placenta.2017.01.125. Epub 2017 Jan 24. Placenta. 2017. PMID: 28292469 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page